Delivery Order SPE2DB22D1002-SPE2DB25FKTP4

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,016.04 firm fixed-price contract is for the supply of VERQUVO 2.5 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 20, 2023. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,039.56, is for the delivery of 90 tablets of the medication VERQUVO 10 MG. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999.00, which provides a global pharmaceutical support vehicle to supply a wide range of medical products...
This is a $1,998.87 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) on June 6, 2025. The contract is for the delivery of VERQUVO 2.5 MG TABLET 30S, a pharmaceutical product, with a period of performance through June 9, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug VERQUVO 10 MG TABLET 30S. The firm-fixed-price contract, valued at $4,396.10, has an ultimate completion date of November 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,039.56 firm fixed-price delivery order is for the supply of VERQUVO 10 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of February 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,867.54 firm fixed-price delivery order is for the supply of VERQUVO 10 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of March 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,979.59, is for the delivery of the prescription medication VERQUVO 2.5 MG TABLET 30S. It is a firm fixed-price contract with an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,933.91 firm fixed price contract is for the delivery of VERQUVO 2.5 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of October 21, 2024 and is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of VERQUVO 2.5 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $6,846.79. The contract has an ultimate completion date of April 7, 2025 and is a Delivery Order under a Firm Fixed Price contract type. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a...
This federal contract award is a delivery order valued at $3,501.47 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of VERQUVO 2.5 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of November 1, 2024 and is a firm fixed price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FKTP4
    Delivery Order

This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide VERQUVO 2.5 MG TABLET 30S. The $1,004.82 contract has an ultimate completion date of October 31, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific task order does not have a set-aside designation, indicating open competition. The contract Award ID number is SPE2DB22D1002|SPE2DB25FKTP4.

Generated 1/29/25, 9:28 AM